Solventum Corp (SOLV) stock
SOLVNYSESurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 5, 2026Score 6/3089% above fair value
$86.48+0.42 (+0.49%)
Close on Nov 18, 2026Market cap $14.72BP/E 97.2Yield –
Solventum net income
Net income is the profit left for shareholders after every expense, interest and tax.
Solventum's net income for the twelve months ending Sep 30, 2026 was $156.00M, down 89.8% year over year. For fiscal 2025 it was $1.56B, up 224.8% from the year before.
Annual net income
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $1.56B | +224.8% |
| FY2024 | Dec 31, 2024 | $479.00M | -64.4% |
| FY2023 | Dec 31, 2023 | $1.35B | +0.2% |
| FY2022 | Dec 31, 2022 | $1.34B | – |
Quarterly net income
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | -$12.00M | -100.9% |
| Q2 FY2026 | Jun 30, 2026 | $92.00M | +2.2% |
| Q1 FY2026 | Mar 31, 2026 | $13.00M | -90.5% |
| Q4 FY2025 | Dec 31, 2025 | $63.00M | +103.2% |
| Q3 FY2025 | Sep 30, 2025 | $1.27B | +937.7% |
| Q2 FY2025 | Jun 30, 2025 | $90.00M | +1.1% |
| Q1 FY2025 | Mar 31, 2025 | $137.00M | -42.2% |
| Q4 FY2024 | Dec 31, 2024 | $31.00M | -88.6% |
| Q3 FY2024 | Sep 30, 2024 | $122.00M | -73.5% |
| Q2 FY2024 | Jun 30, 2024 | $89.00M | -72.3% |
| Q1 FY2024 | Mar 31, 2024 | $237.00M | -19.1% |
| Q4 FY2023 | Dec 31, 2023 | $272.00M | – |
| Q3 FY2023 | Sep 30, 2023 | $460.00M | – |
| Q2 FY2023 | Jun 30, 2023 | $321.00M | – |
| Q1 FY2023 | Mar 31, 2023 | $293.00M | – |
See a number that looks wrong?